These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17470194)

  • 61. Can dietary modification reduce the cardiovascular complications of metabolic syndrome? 'All for one' or 'one for all'?
    Lovegrove JA; Griffin BA
    Expert Rev Cardiovasc Ther; 2011 Apr; 9(4):413-6. PubMed ID: 21517725
    [No Abstract]   [Full Text] [Related]  

  • 62. Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.
    Jain A; Harvey D; Robertson L; Mikhailidis DP; Nair DR
    Int J Clin Pract; 2011 Jun; 65(6):715-6. PubMed ID: 21564448
    [No Abstract]   [Full Text] [Related]  

  • 63. Managing hypertension in cardiology practice: from individual risk factors and the metabolic syndrome to global cardiometabolic risk.
    Dominguez-Rodriguez A
    Int J Clin Pract; 2008 Sep; 62(9):1303-4. PubMed ID: 18793373
    [No Abstract]   [Full Text] [Related]  

  • 64. Critical questions about the metabolic syndrome.
    Greenland P
    Circulation; 2005 Dec; 112(24):3675-6. PubMed ID: 16344398
    [No Abstract]   [Full Text] [Related]  

  • 65. [Diagnosis and treatment of patients with cardiometabolic risk].
    Grupo CONVERGE
    Med Clin (Barc); 2007 Oct; 129(15):588-96. PubMed ID: 17988618
    [No Abstract]   [Full Text] [Related]  

  • 66. Gender differences in the association between changes in the atherogenic index of plasma and cardiometabolic diseases: a cohort study.
    Huang X; Wen S; Huang Y; Huang Z
    Lipids Health Dis; 2024 May; 23(1):135. PubMed ID: 38715126
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 68. Is the concept of 'cardiometabolic risk' more useful than 'metabolic syndrome'?
    Koshiyama H; Taniguchi A; Inagaki N; Seino Y
    Diabet Med; 2007 May; 24(5):571. PubMed ID: 17470194
    [No Abstract]   [Full Text] [Related]  

  • 69. Cardiovascular outcomes for obesity and metabolic syndrome.
    Vega GL
    Obes Res; 2002 Nov; 10 Suppl 1():27S-32S. PubMed ID: 12446855
    [No Abstract]   [Full Text] [Related]  

  • 70. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.
    Després JP; Cartier A; Côté M; Arsenault BJ
    Ann Med; 2008; 40(7):514-23. PubMed ID: 18608131
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.